Evogene (EVGN) Stock Chart & Stock Price History $1.16 -0.02 (-1.69%) As of 10:04 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Evogene Stock Price Performance The Evogene (EVGN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 84.25%, with a year-to-date return of -37.70%. In the past month, the stock has increased 4.02%, reflecting recent market activity. As of the latest close, Evogene traded at $1.19 with a market cap of $6.36 million and volume of 83,624 shares. Five years ago, the stock traded at a split-adjusted price of $10.95, representing a 89.36% decrease over that period. At the time, it had a market cap of $28.33 million and a volume of 870 shares. Receive EVGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-11.07%1 Month Performance+4.02%3 Month Performance-17.78%Year-To-Date Performance-37.70%1 Year Performance-84.25%5 Year Performance-89.36% EVGN Stock Chart for Thursday, May, 22, 2025 EVGN Chart by TradingView Evogene Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$1.27$1.19-6.69%$1.30$1.1783,624 shs$6.36 million05/20/2025$1.34$1.27-5.22%$1.43$1.2796,197 shs$6.81 million05/19/2025$1.31$1.34+2.29%$1.36$1.2850,478 shs$7.19 million05/16/2025$1.23$1.31+6.50%$1.35$1.23116,352 shs$7.03 million05/15/2025$1.22$1.23+0.82%$1.24$1.1923,919 shs$6.60 million05/14/2025$1.22$1.22$1.22$1.1920,968 shs$6.55 million05/13/2025$1.14$1.22+7.02%$1.23$1.1435,967 shs$6.55 million05/12/2025$1.13$1.14+0.66%$1.21$1.1217,977 shs$6.12 million05/09/2025$1.15$1.13-1.52%$1.22$1.1237,123 shs$6.08 million05/08/2025$1.17$1.15-1.71%$1.18$1.1318,377 shs$6.17 million Get the Latest News and Ratings for EVGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$1.14$1.17+2.63%$1.19$1.1338,403 shs$6.28 million05/06/2025$1.16$1.14-1.72%$1.19$1.1451,519 shs$6.12 million05/05/2025$1.18$1.16-1.69%$1.22$1.1563,024 shs$6.22 million05/02/2025$1.15$1.18+2.61%$1.22$1.1843,203 shs$6.33 million05/01/2025$1.13$1.15+1.77%$1.19$1.1238,478 shs$6.17 million04/30/2025$1.17$1.13-3.42%$1.19$1.0957,144 shs$6.06 million04/29/2025$1.15$1.17+1.74%$1.22$1.1254,741 shs$6.28 million04/28/2025$1.11$1.15+3.60%$1.18$1.08100,382 shs$6.17 million04/25/2025$1.11$1.11$1.14$1.0968,059 shs$5.96 million04/24/2025$1.09$1.11+1.83%$1.16$1.05148,075 shs$5.96 million04/23/2025$1.12$1.09-2.68%$1.22$1.09267,783 shs$5.85 million04/22/2025$1.27$1.12-11.81%$1.24$1.05844,206 shs$6.01 million04/21/2025$0.97$1.27+30.93%$1.34$1.0820.11 million shs$6.81 million Related Companies TOMZ Stock Chart ENFY Stock Chart BSLK Stock Chart GURE Stock Chart NITO Stock Chart SNES Stock Chart HGAS Stock Chart CNEY Stock Chart DNMR Stock Chart TANH Stock Chart Receive EVGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EVGN) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
